Galya Blachman

Galya Blachman

Conseiller Juridique Général chez 501 ACQU
49 ans
Consumer Services
Health Technology
Finance

Profil

Galya D.
Blachman
is currently Chief Legal Officer & Head-Business Development at Enliven Therapeutics, Inc. since 2023.
Legal Advisor at 5AM Venture Management LLC since 2022.
Secretary & General Counsel at 5:01 Acquisition Corp.
since 2020.
General Counsel at Biotech Connection-Bay Area, Inc. since 2018.
Formerly Legal Director at Stemcentrx, Inc. from 2012 to 2017.
Also worked as Head-Legal, Research & Development at AbbVie Stemcentrx LLC.
Education includes a doctorate from the University of Cambridge in 2004, a graduate degree from the University of Oxford in 2009, graduate and undergraduate degrees from the University of Cape Town in 2001 and 2000 respectively, and a graduate degree from BPP Law School in 2006.

Postes actifs de Galya Blachman

SociétésPosteDébut
501 ACQU Conseiller Juridique Général 01/09/2020
ENLIVEN THERAPEUTICS, INC. Conseiller Juridique Général 01/07/2023
Conseiller Juridique Général 01/06/2018
Conseiller Juridique Général 01/09/2018

Anciens postes connus de Galya Blachman

SociétésPosteFin
Conseiller Juridique Général 01/01/2017
AbbVie Stemcentrx LLC
Corporate Officer/Principal -
Voir l'expérience en détail de Galya Blachman

Formation de Galya Blachman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

89

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Consumer Services

Consumer Services

Consumer Services

Finance

Consumer Services

AbbVie Stemcentrx LLC

Finance

Health Technology

  1. Bourse
  2. Insiders
  3. Galya Blachman
🔇